Variable | Bone metastasis | |
---|---|---|
HR (95% CI) | P | |
Age (≤56 versus > 56 years) | 0.725(0.286–1.840) | 0.499 |
Gender (male versus female) | 1.864(0.539–6.445) | 0.325 |
HBsAg (negative versus positive) | 1.849(0.425–8.047) | 0.412 |
HCV-Ab (negative versus positive) | 1.707(0.227–12.838) | 0.603 |
AFP, ng/mL (≤ 20 versus > 20) | 1.612(0.574–4.526) | 0.364 |
ALT,U/L (≤ 40 versus > 40) | 0.255(0.034–1.915) | 0.184 |
γ-GT,U/L (≤ 50 versus > 50) | 1.032(0.400–2.662) | 0.949 |
Liver cirrhosis (no versus yes) | 4.662(0.620–35.039) | 0.135 |
Child-Pugh score (A versus B) | 1.155(0.153–8.697) | 0.889 |
Tumor differentiation (I–II versus III–IV) | 1.504(0.597–3.789) | 0.387 |
Tumor size, cm (≤ 5 versus > 5) | 0.657(0.216–1.996) | 0.458 |
Tumor number (single versus multiple) | 0.963(0.373–2.486) | 0.937 |
Tumor encapsulation (complete versus none) | 1.079(0.426–2.737) | 0.872 |
Vascular invasion (no versus yes) | 10.054(3.572–28.302) | < 0.001 |
BCLC stage (0-A versus B-C) | 7.193(2.361–21.919) | 0.001 |
Lnc34a (low versus high) | 5.385(1.558–18.612) | 0.008 |